FMR LLC — SEC insider filings
SEC reporting owner CIK 315066. 62 insider filings on record with FilingPulse; latest filed 2026-11-12.
Transaction summary — filings shown
Covers the 50 most recent of 62 filings on record, filed 2021-10-28 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 347,506 shares, $8,767,813 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 39 legs across 18 filings — 2,261,993 shares, $60,735,624 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 146.
- Largest priced transaction: sale of 854,323 shares @ $30.51 ($26,065,395) in Beam Therapeutics Inc., filed 2024-02-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | 10% owner | 9 | — | 15 legs · 1,275,601 sh · $40,829,358 | 18 |
| Verve Therapeutics, Inc. (VERV) | — | 8 | — | 14 legs · 466,565 sh · $11,296,477 | — |
| Fidelity Private Credit Fund | — | 3 | 3 legs · 347,506 sh · $8,767,813 | — | — |
| Avalyn Pharma Inc. (AVLN) | 10% owner | 2 | — | 4 legs · 228,454 sh · $6,701,004 | 10 |
| Sana Biotechnology, Inc. (SANA) | 10% owner | 1 | — | 4 legs · 290,912 sh · $1,887,320 | — |
| Metsera, Inc. (MTSR) | 10% owner | 7 | — | 2 legs · 461 sh · $21,465 | 23 |
| Structure Therapeutics Inc. (GPCR) | 10% owner | 13 | — | — | 49 |
| Turnstone Biologics Corp. (TSBX) | — | 2 | — | — | 12 |
| Prime Medicine, Inc. (PRME) | — | 1 | — | — | 10 |
| Xilio Therapeutics, Inc. (XLO) | — | 1 | — | — | 10 |
+3 more issuers among the filings shown — every filing appears in the table below.
Insider filings — FMR LLC
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-12 | 4 | Avalyn Pharma Inc. (AVLN) | Sale (S): 173,661 @ $29.06 · Sale (S): 1,339 @ $29.75 · Sale (S): 5,565 @ $29.56 · Sale (S): 47,889 @ $30.28 | EDGAR |
| 2026-07-24 | 4 | Structure Therapeutics Inc. (GPCR) | Sale (S): 1,367 (derivative) @ $50.07 · Sale (S): 16,085 (derivative) @ $50.07 | EDGAR |
| 2026-06-29 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 33,372 @ $35.12 · Sale (S): 251,488 @ $35.26 | EDGAR |
| 2026-05-05 | 4 | Avalyn Pharma Inc. (AVLN) | Conversion (C): 727,585 · Conversion (C): 80,291 · Conversion (C): 872,868 · Conversion (C): 225,843 · Conversion (C): 377,948 · Conversion (C): 727,585 (derivative) · +4 more | EDGAR |
| 2026-04-16 | 4 | Structure Therapeutics Inc. (GPCR) | Sale (S): 1,367 (derivative) @ $55.07 · Sale (S): 16,085 (derivative) @ $55.07 | EDGAR |
| 2026-01-20 | 4 | Structure Therapeutics Inc. (GPCR) | Sale (S): 465 (derivative) @ $82.10 · Sale (S): 330 (derivative) @ $83.35 · Sale (S): 552 (derivative) @ $84.22 · Sale (S): 20 (derivative) @ $85.04 · Sale (S): 5,477 (derivative) @ $82.10 · Sale (S): 3,880 (derivative) @ $83.35 · +2 more | EDGAR |
| 2025-12-10 | 4 | Structure Therapeutics Inc. (GPCR) | Sale (S): 709 (derivative) @ $92.52 · Sale (S): 183 (derivative) @ $94 · Sale (S): 475 (derivative) @ $94.61 · Sale (S): 1,414 (derivative) @ $61.05 · Sale (S): 1,320 (derivative) @ $61.45 · Sale (S): 8,337 (derivative) @ $92.52 · +4 more | EDGAR |
| 2025-11-17 | 4 | Metsera, Inc. (MTSR) | Other (J): 3,010 · Other (J): 2,230,450 | EDGAR |
| 2025-11-12 | 4 | Metsera, Inc. (MTSR) | Gift (G): 860,722 @ $0 | EDGAR |
| 2025-11-05 | 4 | Metsera, Inc. (MTSR) | Other (J): 3,189,540 @ $0 · Other (J): 47,843 @ $0 · Other (J): 47,843 @ $0 · Other (J): 2,115 @ $0 · Other (J): 2,356,274 @ $0 · Sale (S): 193 @ $61.23 · +2 more | EDGAR |
| 2025-10-29 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 459 @ $26.68 | EDGAR |
| 2025-10-08 | 4 | Beam Therapeutics Inc. (BEAM) | Gift (G): 1,232,434 @ $0 | EDGAR |
| 2025-10-08 | 4 | Metsera, Inc. (MTSR) | Gift (G): 633,715 @ $0 | EDGAR |
| 2025-09-12 | 4/A | Metsera, Inc. (MTSR) | Other (J): 1,107,547 @ $0 | EDGAR |
| 2025-09-04 | 4 | Metsera, Inc. (MTSR) | Other (J): 1,350,000 @ $0 · Other (J): 20,250 @ $0 · Other (J): 20,250 @ $0 · Other (J): 895 @ $0 · Other (J): 997,312 @ $0 · Other (J): 997,044 @ $0 · +2 more | EDGAR |
| 2025-08-01 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 48,374 @ $20.50 | EDGAR |
| 2025-08-01 | 4 | Structure Therapeutics Inc. (GPCR) | Sale (S): 26,310 (derivative) @ $17.87 | EDGAR |
| 2025-02-10 | 4 | Structure Therapeutics Inc. (GPCR) | Sale (S): 41 (derivative) @ $30.54 | EDGAR |
| 2025-02-05 | 4 | Metsera, Inc. (MTSR) | Conversion (C): 1,418,606 · Conversion (C): 3,120,934 · Conversion (C): 1,418,606 (derivative) · Conversion (C): 3,120,934 (derivative) | EDGAR |
| 2025-01-10 | 4 | Sana Biotechnology, Inc. (SANA) | Sale (S): 100,000 @ $6.11 · Sale (S): 25,000 @ $6.50 · Sale (S): 164,912 @ $6.71 · Sale (S): 1,000 @ $7.26 | EDGAR |
| 2024-09-18 | 4 | Bicara Therapeutics Inc. (BCAX) | Conversion (C): 10,818 · Conversion (C): 712,430 · Conversion (C): 392,085 · Conversion (C): 10,818 (derivative) · Conversion (C): 712,430 (derivative) · Conversion (C): 392,085 (derivative) | EDGAR |
| 2024-04-19 | 4 | Structure Therapeutics Inc. (GPCR) | Holdings only — no transactions reported | EDGAR |
| 2024-03-18 | 4 | Structure Therapeutics Inc. (GPCR) | Sale (S): 21,997 (derivative) @ $35 | EDGAR |
| 2024-02-15 | 4 | Beam Therapeutics Inc. (BEAM) | Sale (S): 410 @ $30.28 · Sale (S): 1,155 @ $30.93 · Sale (S): 854,323 @ $30.51 · Sale (S): 45,677 @ $31.34 | EDGAR |
| 2024-02-15 | 4 | Structure Therapeutics Inc. (GPCR) | Sale (S): 525 (derivative) @ $47.24 | EDGAR |
| 2024-01-31 | 4 | Fidelity Private Credit Fund | Holdings only — no transactions reported | EDGAR |
| 2024-01-11 | 4 | Turnstone Biologics Corp. (TSBX) | Holdings only — no transactions reported | EDGAR |
| 2023-12-27 | 4 | Beam Therapeutics Inc. (BEAM) | Other (J): 29,549 @ $0 | EDGAR |
| 2023-12-27 | 4 | Structure Therapeutics Inc. (GPCR) | Other (J): 25,410 (derivative) @ $0 | EDGAR |
| 2023-12-07 | 4 | Structure Therapeutics Inc. (GPCR) | Sale (S): 1,368 (derivative) @ $62.46 · Sale (S): 16,086 (derivative) @ $62.46 | EDGAR |
| 2023-11-29 | 4 | Fidelity Private Credit Fund | Purchase (P): 391.50 @ $25.54 · Purchase (P): 391.50 @ $25.54 | EDGAR |
| 2023-10-23 | 4 | Structure Therapeutics Inc. (GPCR) | Sale (S): 1,368 (derivative) @ $65.64 · Sale (S): 16,086 (derivative) @ $65.64 | EDGAR |
| 2023-09-21 | 4 | Neumora Therapeutics, Inc. (NMRA) | Conversion (C): 3,475,646 · Conversion (C): 84,965 · Conversion (C): 63,724 · Conversion (C): 88,289 · Conversion (C): 63,724 (derivative) · Conversion (C): 3,475,646 (derivative) · +2 more | EDGAR |
| 2023-07-27 | 4 | Turnstone Biologics Corp. (TSBX) | Conversion (C): 91,663 · Conversion (C): 106,496 · Conversion (C): 150,809 · Conversion (C): 483,684 · Conversion (C): 296,396 · Conversion (C): 4,939 · +6 more | EDGAR |
| 2023-06-29 | 4 | Fidelity Private Credit Fund | Purchase (P): 346,722.78 @ $25.23 | EDGAR |
| 2023-02-09 | 4 | Structure Therapeutics Inc. (GPCR) | Conversion (C): 965,115 · Conversion (C): 57,523 · Conversion (C): 10,154 · Conversion (C): 7,411 · Conversion (C): 6,947 · Conversion (C): 3,572,022 · +12 more | EDGAR |
| 2022-10-26 | 4 | Prime Medicine, Inc. (PRME) | Conversion (C): 4,124,375 · Conversion (C): 98,967 · Conversion (C): 11,015 · Conversion (C): 3,805,080 · Conversion (C): 423,509 · Conversion (C): 4,124,375 (derivative) · +4 more | EDGAR |
| 2022-09-08 | 4 | Beam Therapeutics Inc. (BEAM) | Other (J): 25,620 @ $0 · Other (J): 551 @ $0 · Sale (S): 551 @ $54.25 | EDGAR |
| 2022-08-08 | 4 | Beam Therapeutics Inc. (BEAM) | Other (J): 800,000 @ $0 · Other (J): 375,536 @ $0 · Other (J): 375,369 @ $0 · Other (J): 180,366 @ $0 · Other (J): 167,564 @ $0 · Other (J): 20,159 @ $0 · +3 more | EDGAR |
| 2022-07-28 | 4 | Verve Therapeutics, Inc. (VERV) | Holdings only — no transactions reported | EDGAR |
| 2022-07-14 | 4 | Verve Therapeutics, Inc. (VERV) | Sale (S): 100,000 @ $19.98 · Sale (S): 63,000 @ $22.04 | EDGAR |
| 2022-07-06 | 4 | Verve Therapeutics, Inc. (VERV) | Sale (S): 38,775 @ $15.66 | EDGAR |
| 2022-07-01 | 4 | Verve Therapeutics, Inc. (VERV) | Sale (S): 4,047 @ $15.50 · Sale (S): 30,362 @ $15.60 · Sale (S): 18,810 @ $15.21 | EDGAR |
| 2022-04-14 | 4 | Beam Therapeutics Inc. (BEAM) | Other (J): 978,503 @ $0 · Other (J): 509,490 @ $0 · Other (J): 509,332 @ $0 · Other (J): 137,845 @ $0 · Other (J): 128,333 @ $0 · Other (J): 15,406 @ $0 · +5 more | EDGAR |
| 2022-03-11 | 4 | Verve Therapeutics, Inc. (VERV) | Sale (S): 3,971 @ $29.01 | EDGAR |
| 2022-02-11 | 4 | Verve Therapeutics, Inc. (VERV) | Sale (S): 13,190 @ $29.46 | EDGAR |
| 2022-02-03 | 4 | Verve Therapeutics, Inc. (VERV) | Sale (S): 35,574 @ $29.04 | EDGAR |
| 2022-01-28 | 4 | Verve Therapeutics, Inc. (VERV) | Sale (S): 14,918 @ $29.67 · Sale (S): 88,989 @ $31.12 · Sale (S): 45,946 @ $31.96 · Sale (S): 8,736 @ $29.26 · Sale (S): 247 @ $30.02 | EDGAR |
| 2021-11-12 | 4 | Toast, Inc. (TOST) | Holdings only — no transactions reported | EDGAR |
| 2021-10-28 | 4 | Xilio Therapeutics, Inc. (XLO) | Conversion (C): 789,473 · Conversion (C): 686,499 · Conversion (C): 28,703 · Conversion (C): 372,215 · Conversion (C): 4,465 · Conversion (C): 7,500,000 (derivative) · +4 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=315066 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs